September 2024 — Pharma News Archive

Every regulatory action (90), Phase 3 readout (0), and patent expiry (9) tracked in September 2024. Sourced from Drugs@FDA, EMA EPAR, ClinicalTrials.gov, USPTO Orange Book.

90 regulatory actions 0 Phase 3 readouts 9 patent expiries

Regulatory actions (90)

Phase 3 trial readouts (0)

No Phase 3 readouts tracked in this month.

Patent expiries (9)

Subscribe to ongoing alerts

This page is a permanent monthly archive. For ongoing alerts as new events happen:

See also